Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
|Eligible Ages||18 Years - 75 Years|
- - Patients aged 18 to 75 years; - Patients with non-segmental vitiligo; - Patients with plaque psoriasis; - Patients with atopic dermatitis; - Patients with alopecia areata sclerosis; - written consent, free, informed and signed by the patient and the investigator (before any examination required by the study); - Subject affiliated or beneficiary of a social security system.
- - Patients with segmental vitiligo - Patients under local treatment (topical corticosteroid-Calcineurin inhibitor) for less than two weeks.
- - Patients on therapy, systemic treatments: acitretin, methotrexate, cyclosporine, Apremilast, infliximab, adalimumab, etanercept, ustekinumab, secukinumab, ixekizumab, dupilumab) for less than 4 weeks.
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
|University Hospital, Bordeaux|
The person who is responsible for the scientific and technical direction of the entire clinical study.
|Julien SENESCHAL, MD, PhD|
|Principal Investigator Affiliation||University Hospital, Bordeaux|
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
|Overall Status||Not yet recruiting|
The disease, disorder, syndrome, illness, or injury that is being studied.
|Vitiligo, Psoriasis, Alopecia Areata, Atopic Dermatitis|
This study was a single-center prospective study to collect blood and skin tissue at the time of consultation with a patient with non-segmental vitiligo, psoriasis, atopic dermatitis or alopecia areata, in order to better understand and compare blood and skin immune response in chronic inflammatory skin disorders: psoriasis, alopecia areata, atopic dermatitis and vitiligo.
Patients aged 18 to 75 years with non-segmental vitiligo;
Patients aged 18 to 75 years with plaque psoriasis;
: atopic dermatitis
Patients aged 18 to 75 years with atopic dermatitis;
: alopecia areata
Patients aged 18 to 75 years with alopecia areata sclerosis;
Biological: - Blood samples
Blood samples: serum and PBMC
Biological: - Skin biopsies
These superficial skin biopsies under local anesthesia in skin areas with the exception of the face and folds.
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.